Robert Hendren
Overview
Explore the profile of Robert Hendren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
687
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palser E, Miller Z, Licata A, Yabut N, Sudarsan S, Tee B, et al.
Neurocase
. 2022 Nov;
28(5):419-431.
PMID: 36450280
Diagnostic criteria for dyslexia describe specific reading difficulties, and single-deficit models, including the phonological deficit theory, have prevailed. Children seeking diagnosis, however, do not always show phonological deficits, and may...
2.
Hossain B, Bent S, Hendren R
Dyslexia
. 2021 Mar;
27(3):342-354.
PMID: 33733531
The purpose of this study was to examine the association between anxiety and overall academic performance (AP) in children with reading disorder (RD). This two-year longitudinal cohort study included 128...
3.
Sturm V, Roy A, Datta S, Wang C, Sible I, Holley S, et al.
Cortex
. 2020 Dec;
134:278-295.
PMID: 33316603
Dyslexia is a neurodevelopmental disorder mainly defined by reading difficulties. During reading, individuals with dyslexia exhibit hypoactivity in left-lateralized language systems. Lower activity in one brain circuit can be accompanied...
4.
Kaliukhovich D, Manyakov N, Bangerter A, Ness S, Skalkin A, Boice M, et al.
J Autism Dev Disord
. 2020 Sep;
51(7):2369-2380.
PMID: 32951157
Participants with autism spectrum disorder (ASD) (n = 121, mean [SD] age: 14.6 [8.0] years) and typically developing (TD) controls (n = 40, 16.4 [13.3] years) were presented with a...
5.
Ness S, Pandina G, Jagannatha S, Wathen K, Bangerter A, Manyakov N, et al.
Nat Rev Drug Discov
. 2020 Jun;
19(6):427.
PMID: 32494051
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
6.
Bangerter A, Chatterjee M, Manfredonia J, Manyakov N, Ness S, Boice M, et al.
Mol Autism
. 2020 May;
11(1):31.
PMID: 32393350
Background: Reduction or differences in facial expression are a core diagnostic feature of autism spectrum disorder (ASD), yet evidence regarding the extent of this discrepancy is limited and inconsistent. Use...
7.
Bangerter A, Chatterjee M, Manyakov N, Ness S, Lewin D, Skalkin A, et al.
Front Neurosci
. 2020 Apr;
14:211.
PMID: 32265629
Objective: The relationship between sleep (caregiver-reported and actigraphy-measured) and other caregiver-reported behaviors in children and adults with autism spectrum disorder (ASD) was examined, including the use of machine learning to...
8.
Ness S, Pandina G, Jagannatha S, Wathen K, Bangerter A, Manyakov N, et al.
Nat Rev Drug Discov
. 2020 Apr;
19(4):219-220.
PMID: 32242150
No abstract available.
9.
Herscu P, Handen B, Eugene Arnold L, Snape M, Bregman J, Ginsberg L, et al.
J Autism Dev Disord
. 2019 Jul;
50(9):3233-3244.
PMID: 31267292
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that reduces obsessive-compulsive symptoms. There is limited evidence supporting its efficacy for repetitive behaviors (RRBs) in autistic spectrum disorder (ASD). We conducted...
10.
Bangerter A, Manyakov N, Lewin D, Boice M, Skalkin A, Jagannatha S, et al.
JMIR Ment Health
. 2019 Mar;
6(3):e11365.
PMID: 30912762
Background: Currently, no medications are approved to treat core symptoms of autism spectrum disorder (ASD). One barrier to ASD medication development is the lack of validated outcome measures able to...